Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs.
about
Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksSelective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety.Impact of patient sample on costs of events in pharmacoeconomic models.Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study.Gastroprotection and effect of the simultaneous administration of Cuachalalate (Amphipterygium adstringens) on the pharmacokinetics and anti-inflammatory activity of diclofenac in rats.
P2860
Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treatment costs to prevent or ...... events associated with NSAIDs.
@ast
Treatment costs to prevent or ...... events associated with NSAIDs.
@en
type
label
Treatment costs to prevent or ...... events associated with NSAIDs.
@ast
Treatment costs to prevent or ...... events associated with NSAIDs.
@en
prefLabel
Treatment costs to prevent or ...... events associated with NSAIDs.
@ast
Treatment costs to prevent or ...... events associated with NSAIDs.
@en
P2093
P1433
P1476
Treatment costs to prevent or ...... events associated with NSAIDs.
@en
P2093
Alan N Barkun
Elham Rahme
Marc Bardou
Viviane Adam
P304
P356
10.2165/00002018-200427130-00004
P577
2004-01-01T00:00:00Z
P6179
1000566224